European Companies Search Engine
7 trademark filings (4 wordmarks, 1 figurative mark, 2 word figurative marks): ACTION - Achieving Control Through Insulin plus Oral ageNts, DoseMan, NovoLife, Redefiniendo la Obesidad … BdlYear 2017 European Union Intellectual Property Office (Trade Marks)
Text
CVR 24256790
| 19/02/2017 | Figurative mark |
| 28/06/2017 | Word figurative mark: “IMPROVE“ |
| 08/01/2017 | Word figurative mark: “LEAD programme Liraglutide Effect and Action in Diabetes“ |
| 05/03/2017 | Wordmark: “ACTION - Achieving Control Through Insulin plus Oral ageNts“ |
| 19/02/2017 | Wordmark: “DoseMan“ |
| 19/10/2017 | Wordmark: “NovoLife“ |
| 05/07/2017 | Wordmark: “Redefiniendo la Obesidad“ |
This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Novo Nordisk A/S, Bagsværd, Denmark.
The visualizations for "7 trademark filings (4 wordmarks, 1 figurative mark, 2 word figurative marks): ACTION - Achieving Control Through Insulin plus Oral ageNts, DoseMan, NovoLife, Redefiniendo la Obesidad …"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
